Holds one active US DMF for midodrine, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF for midodrine, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds 2 active US DMFs for midodrine, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.
Holds one active US DMF for midodrine, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for midodrine, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for midodrine, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for midodrine, filing since 2024. Its 2025 FDA inspection closed as VAI.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Midodrine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free